CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed and refractory lymphoma

Blood Advances ◽

10.1182/bloodadvances.2021006232 ◽

2022 ◽

Author(s):

Yelei Guo ◽

Chuan Tong ◽

Liping Su ◽

Wenying Zhang ◽

Hejin Jia ◽

...

Keyword(s):

T Cells ◽

Car T Cells ◽

Car T ◽

Refractory Lymphoma

Download Full-text

Abstract A041: CD19-targeting third generation CAR T cells for relapsed and refractory lymphoma and leukemia – report from the Swedish phase I/IIa trial

10.1158/2326-6074.cricimteatiaacr15-a041 ◽

2016 ◽

Author(s):

Gunilla Enblad ◽

Hannah Karlsson ◽

Kristina I. Wikstrom ◽

Magnus Essand ◽

Barbara Savoldo ◽

...

Keyword(s):

T Cells ◽

Phase I ◽

Third Generation ◽

Car T Cells ◽

Car T ◽

Refractory Lymphoma

Download Full-text

Decision letter for "CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma"

10.1002/eji.201948457/v2/decision1 ◽

2020 ◽

Keyword(s):

Hepatocellular Carcinoma ◽

T Cells ◽

Car T Cells ◽

Download Full-text

Review for "CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma"

10.1002/eji.201948457/v1/review2 ◽

2019 ◽

Keyword(s):

Hepatocellular Carcinoma ◽

T Cells ◽

Car T Cells ◽

Download Full-text

Autologous Active IL-7 Receptor Co-expressing GD2-specific CAR T-cells

10.32388/ohva3w ◽

2020 ◽

Author(s):

Keyword(s):

T Cells ◽

Car T Cells ◽

Download Full-text

13 / Evaluation of immunosuppressive surface molecules, essential for resistance to CAR T-cells

10.26226/morressier.5b3b802db1b87b000eced9d4 ◽

2018 ◽

Author(s):

Titov Aleksei

Keyword(s):

T Cells ◽

Surface Molecules ◽

Car T Cells ◽

Download Full-text

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Case Medical Research ◽

10.31525/ct1-nct03881774 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

B Cell ◽

B Cell Malignancies ◽

Car T Cells ◽

Download Full-text

Modified Immune Cells (Autologous CAR T Cells) in Treating Patients With Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Case Medical Research ◽

10.31525/ct1-nct03907527 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Fallopian Tube ◽

Immune Cells ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Car T Cells ◽

Platinum Resistant ◽

Download Full-text

Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma

Case Medical Research ◽

10.31525/ct1-nct04119024 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Immune Cells ◽

Conditioning Regimen ◽

Car T Cells ◽

Download Full-text

A Clinical Study of CAR-T Cells Treatment for Children With CD19+/CD22+ R/R ALL and Lymphoma

Case Medical Research ◽

10.31525/ct1-nct04204161 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Clinical Study ◽

Car T Cells ◽

Download Full-text

Anti-CD19 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphomas

Case Medical Research ◽

10.31525/ct1-nct04196205 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Acute Lymphoblastic Leukemia ◽

Lymphoblastic Leukemia ◽

Car T Cells ◽

Download Full-text